Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CID-797718 是一种潜在的 PKD 结合剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,330 | 现货 | ||
2 mg | ¥ 1,960 | 现货 | ||
5 mg | ¥ 2,950 | 现货 | ||
10 mg | ¥ 4,220 | 现货 | ||
25 mg | ¥ 6,730 | 现货 | ||
50 mg | ¥ 9,130 | 现货 | ||
100 mg | ¥ 12,300 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 3,210 | 现货 |
产品描述 | CID-797718 is a protein kinase D1 (PKD1) inhibitor. |
激酶实验 | HDAC selectivity assays: Dose-response studies are done with ten concentrations in a threefold dilution series from a maximum final compound concentration of 100 μM in the reaction mixture and are conducted at Reaction Biology Corp. All assays are based on the same principle as the HDAC9 assay described above: the deacetylation of acetylated or trifluoroacetylated lysine residues on fluorogenic peptide substrates by HDAC. HDAC1, HDAC2, HDAC3, HDAC6, HDAC10 and HDAC11 used a substrate based on residues 379-382 of p53 (Arg-His-Lys-Lys(Ac)). For HDAC8, the diacetylated peptide substrate, based on residues 379–382 of p53 (Arg-His-Lys(Ac)-Lys(Ac)), is used. HDAC4, HDAC5, HDAC7 and HDAC9 assays used the class IIa HDAC–specific fluorogenic substrate (Boc-Lys(trifluoroacetyl)-AMC). All reactions are done with 50 μM HDAC substrate in assay buffer (50 mM Tris-HCl, pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 1 mg/mL BSA) containing 1% DMSO final concentration; incubated for 2 h at 30 °C; and developed with trichostatin A and trypsin. |
别名 | CID 797718 |
分子量 | 217.22 |
分子式 | C12H11NO3 |
CAS No. | 370586-05-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (230.18 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.6036 mL | 23.0181 mL | 46.0363 mL | 115.0907 mL |
5 mM | 0.9207 mL | 4.6036 mL | 9.2073 mL | 23.0181 mL | |
10 mM | 0.4604 mL | 2.3018 mL | 4.6036 mL | 11.5091 mL | |
20 mM | 0.2302 mL | 1.1509 mL | 2.3018 mL | 5.7545 mL | |
50 mM | 0.0921 mL | 0.4604 mL | 0.9207 mL | 2.3018 mL | |
100 mM | 0.046 mL | 0.2302 mL | 0.4604 mL | 1.1509 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CID-797718 370586-05-3 Cell Cycle/Checkpoint Metabolism Serine/threonin kinase CID797718 inhibit CID 797718 Inhibitor inhibitor